Conclusion: Where Do We Go from Here?
The damage done to you and your family by Lipitor side effects may not be reversible (or easily reversible). But you do not have to stand idly by and stay passive in the face of the events. Depending on circumstances, you may be able to take aggressive, effective legal action to obtain compensation and justice […]
Conclusion: the Risperdal Debacle
Johnson & Johnson and its subsidiary, Janssen, are not evil companies. And Risperdal is not an “evil” drug. In fact, atypical antipsychotics like Risperdal no doubt help thousands of patients a year recover from potentially debilitating symptoms and live lives that are happier, more productive, and less painful. At the same time, grievous harm has […]
A 30,000 Foot Perspective on a Profound Legal Issue: Lipitor Lawsuits
Defenders of Pfizer and other drug companies (and of the “malevolent cholesterol hypotheisis”) counter criticisms by attacking Lipitor’s detractors for sensationalizing the dangers and underestimating the benefits of statin drugs. But what is the truth? What does the science actually say? How can educated consumers (and doctors) separate truth from fiction? What is the line between legitimate […]
A Brief Look at Legal Actions Against Johnson & Johnson and Janssen
On April 11, 2012, Janssen Pharmaceuticals and Johnson & Johnson got some really bad news: A judge in Arkansas fined the drug makers $1.2 billion, after a jury agreed that the company had dramatically and dangerously undersold the potential risks of the drug. The judge said that the drug maker committed 240,000 violations of Arkansas’ […]
January 2014: A Shocking Study with Revolutionary Implications
In January 2014, a population study published in the Journal of Negative Results in Medicine shook the statin industry to its core and forced tens of thousands of doctors the world over to reconsider the utility of statin therapy. Actually, it did no such thing. But perhaps it should have. The study examined statin use […]
More Science Linking Risperdal to Gynecomastia
Let us consider a few additional articles from the medical literature. The point is not to revel in the details, but rather to show that many researchers throughout the years found evidence linking Risperdal to high prolactin levels and linking high prolactin with gynecomastia. Note that, while this research was being done, Johnson & Johnson […]
One Last Thought to Ponder about Statins and Lipitor
A blogger at the website HealthyCriticism.com shared this trenchant, if sad, thought on his blog. It is worth pondering: “Between the billions in manufacture profits and the positive reviews of the data, not to mention the effects (placebo and otherwise) experienced by patients, you might wonder what the problem is. Isn’t everyone happy? Well, for […]
Resources for Granuflo Victims and Their Families
· Granuflo Lawsuits Could See Consolidation · FDA Issues GranuFlo Recall · A Class I Recall of Granuflo is Issued · GranuFlo and NaturaLyte Heart Attack Risk · Questions and Answers About Frensenius and its Dialysis Products GranuFlo and NaturaLyte If you have questions about a potential GranuFlo case — that is, if you or […]
Low Doses of Risperdal Do Not Lead to Gynecomastia?
Here is another compelling article from the literature: “Risperidone induced symptomatic hyperprolactinemia in adolescents” from the Journal of Clinical Psychopharmacology, April 2006, Volume 26, Issue 2, Pages 167 and 171. In the abstract, the authors noted: “Studies performed in adult patients unambiguously demonstrate a marked effect of risperidone on prolactin blood levels, with possible clinical […]
Authorities Outraged By Sloppy Statin Science
Fiona Godlee, the editor of the British Medical Journal — one of the most respected medical journals in the world — put the problem bluntly: “there is a concern underlying [the authors’] critique that will be familiar to BMJ readers. It is that all of the trials included in the CTT meta-analysis were funded by […]